Form 4: Bausch & Lomb Director Kavanagh Receives Annual Grant of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Sarah B. Kavanagh receives 14,696 restricted stock units (RSUs) as part of the annual grant under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.

Summary

  • On August 2, 2024, Sarah B. Kavanagh, a director of Bausch & Lomb Corp, was granted 14,696 restricted stock units (RSUs).
  • These RSUs were granted under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
  • The RSUs vest immediately prior to the next annual meeting of shareholders and will be settled in common shares of Bausch & Lomb Corporation.
  • Following this transaction, Kavanagh beneficially owns 33,361 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally neutral to positive as it aligns director interests with shareholders. There are no indications of negative performance or concerning issues.

Positives

  • The grant of RSUs aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages continued service until the next annual meeting.

Future Outlook

The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Industry Context

Grants of restricted stock units to directors are a common practice in publicly traded companies to incentivize and retain board members.

Comparison to Industry Standards

  • Director compensation packages, including RSU grants, vary significantly across industries and company sizes.
  • Comparing the size of this RSU grant to those of directors at similarly sized companies in the healthcare or consumer goods sectors would provide a benchmark for assessing its relative value.
  • Companies like Johnson & Johnson, Novartis, and Alcon could be considered peers for comparison purposes.

Stakeholder Impact

  • The RSU grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
08/02/2024Date of RSU transaction
08/06/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.